Midgard Science

Labs / ADME, DMPK & toxicology

Ajinomoto Bio-Pharma Services

San Diego, CA, United States · ajibio-pharma.ajinomoto.com

GLP · GMP

Ajinomoto Bio-Pharma Services is a global network of specialized CDMOs serving biopharma programs across small molecules, oligonucleotides, peptides, gene therapy, proteins, and bioconjugates. It operates sites in Belgium, India, Japan, and the United States and supports development and manufacturing for clients worldwide.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Small Molecule Manufacturing

    Develops and manufactures APIs and intermediates, including specialized solutions for complex chemistry.

  • Oligonucleotide Manufacturing

    Provides solid-phase synthesis and AJIPHASE™ liquid-phase technology for oligonucleotide development and manufacturing.

  • Peptide Manufacturing

    Produces complex and high-volume peptides, including GLP-1 analogs.

  • Gene Therapy Manufacturing

    Supports AAV development and GMP manufacturing through Forge Biologics.

  • Protein Manufacturing

    Produces recombinant proteins through secretion for simplified purification and higher purity.

  • ADC & Bioconjugation Services

    Provides site-specific conjugation and linker technologies for ADCs and other bioconjugates.

  • Continuous Flow Chemistry

    Offers continuous flow chemistry services for small molecule development and manufacturing.

  • High Potency API Manufacturing

    Provides manufacturing support for high potency APIs.

  • Research-Grade Oligonucleotides

    Offers research-grade oligonucleotide products.

  • Clinical & Commercial Oligonucleotide Manufacturing

    Supports oligonucleotide programs from clinical development through commercial supply.

  • Site-Specific Conjugation Technology

    Uses AJICAP™ to enable site-specific antibody conjugation and linker attachment.

What they work on

Modalities
Small molecule, Antibody, Bispecific, ADC, Peptide, Oligonucleotide, mRNA, Viral vector, Recombinant protein, LNP / formulation
Species and models
Corynebacterium glutamicum, native IgG antibodies
Assays and studies
analytical characterization, process optimization, method validation, stability studies, product characterization
Instruments and platforms
IEX, RP-LC, UF/DF
Scale and capacity
solid-phase synthesis from μg to several kg, AJIPHASE™ up to 200 kg/batch, gr grams to 200 kg/batch, largest reactor used in GMP manufacturing: 8,000L, enzymatic siRNA synthesis from several kilograms up to 200 kg, GenClip™ long RNA from 100 to 500 mer
Type
CRDMO
Sites
Wetteren, Belgium · Osaka, Japan · Belgium, Belgium · India, India · Japan, Japan · United States, United States
Team
2,000+ employees worldwide
Quality
GMP (oligonucleotide manufacturing) · ICH guidelines (stability programs) · PMDA audited (Osaka oligonucleotide site)
Serves
worldwide

Public records

FDA establishment
1000542796
FDA drug establishment
Ajinomoto Co., Inc. source
FDA drug establishment registration
1000542796 · LABEL source

Similar labs. Aurigene Pharmaceutical Services, Sparx BIO, Sai Life, Transcenta Holding

Found in the Biocom California CRO directory. Listing built from ajibio-pharma.ajinomoto.com. Work here? Claim this listing.

Ajinomoto Bio-Pharma Services · Midgard Science